S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 64,125.19 +0.35%
Next Bullish Trade
Sign in
ILMN

Illumina, Inc. ILMN

$186.65 -3.60 (-1.89%)
Neutral · +0.68σ
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · ILMN

Momentum reads · latest daily bar
Last
$186.65
-3.60 (-1.89%)
Mkt cap
$28.2B
Healthcare
RSI(14)
58.3
neutral
Stochastic %K
62.1
neutral
MFI(14)
62.7
neutral
ADX(14)
39.0
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $1.1B $0.1B $0.2B $0.3B 12.3% 19.2%
2025-12-31 $1.2B $0.3B $0.2B $0.3B 28.8% 18.2%
2025-09-30 $1.1B $0.1B $0.2B $0.3B 13.8% 20.9%
2025-06-30 $1.1B $0.2B $0.2B $0.2B 22.2% 20.2%
2025-03-31 $1.0B $0.1B $0.2B $0.2B 12.6% 15.8%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare ILMN vs peers

Line ILMN up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing ILMN MSFT× AMZN×
Sector peers + LLY + UNH + JNJ + MRK + ABBV + PFE
Popular + AAPL + NVDA + GOOG + META + TSLA + AVGO
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP
Verdict
Weighted score 0-100 across 3 tickers · best in green
#3
ILMN
score 32.2
5/5 inputs
Momentum dominates at 100 with 40.63% three-month gain, but zero growth and sentiment scores drag overall rank down.
value 25growth 0quality 40momentum 100sentiment 0
#1
MSFT
score 63.7
5/5 inputs
Quality leads at 100 with 46.3% operating margin plus 100 sentiment score from 41.74% analyst upside overcomes weak momentum.
value 72growth 63quality 100momentum 0sentiment 100
#2
AMZN
score 58.2
5/5 inputs
Growth scores 94 on 74.8% EPS expansion, but quality weakness at 24 from 12.2% net margin limits ranking.
value 64growth 94quality 24momentum 34sentiment 57
ILMN
Illumina, Inc.
$186.65
-1.89%
Snapshot
Price 186.65
Day % -1.89
1M % 13.62
3M % 40.63
YTD % 38.93
Market cap 28240144384.0
ADV ($) 345977041.786438
Beta 1.469
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 2.54
Dist ATR (σ) 0.68
OdysseyHQ grade —
Confluence 1
Valuation
P/E (ttm) 33.87477
P/E (fwd) 31.459738
P/S 6.428442
EV/EBITDA 25.653
P/B 10.602101
FCF yield 0.0299
PEG 3.32
Growth
Revenue yoy 0.048
EPS yoy 0.061
FCF yoy —
Revenue trend 8Q
Quality
Gross margin 0.6829
Operating margin 0.18332
Net margin 0.19417
ROE 0.33822
ROA 0.08683
Debt / Equity 0.95
Interest cov. 11.75
Technicals
RSI(14) 58.3
MACD signal neutral
vs 50-DMA 13.12
vs 200-DMA 38.41
vs 52w high -5.09
HV-30 40.8
Sentiment
Analyst rec 2.35
Target upside -10.19
Insider buy-sell 90d -24
Risk
Short interest 8.17
Days to cover 3.64
Next earnings 2026-07-30
Full ILMN dashboard →
MSFT
Microsoft Corporation
$393.82
-1.82%
Snapshot
Price 393.82
Day % -1.82
1M % -0.0
3M % -6.29
YTD % -16.73
Market cap 2925466222592.0
ADV ($) 15501831798.361267
Beta 1.13
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 1.16
Dist ATR (σ) 0.37
OdysseyHQ grade —
Confluence 0
Valuation
P/E (ttm) 23.86788
P/E (fwd) 20.324642
P/S 9.191689
EV/EBITDA 16.116
P/B 7.0606165
FCF yield 0.0127
PEG 1.21
Growth
Revenue yoy 0.183
EPS yoy 0.234
FCF yoy —
Revenue trend 8Q
Quality
Gross margin 0.68309
Operating margin 0.46326
Net margin 0.39341998
ROE 0.34013999
ROA 0.14814
Debt / Equity 0.3
Interest cov. 52.84
Technicals
RSI(14) 51.9
MACD signal neutral
vs 50-DMA -1.92
vs 200-DMA -10.36
vs 52w high -29.1
HV-30 34.3
Sentiment
Analyst rec 1.31579
Target upside 41.74
Insider buy-sell 90d 20
Risk
Short interest 1.2
Days to cover 1.84
Next earnings 2026-07-29
Full MSFT dashboard →
AMZN
Amazon.com, Inc.
$247.23
-1.06%
Snapshot
Price 247.23
Day % -1.06
1M % 0.5
3M % -0.99
YTD % 9.15
Market cap 2659480240128.0
ADV ($) 12189345134.532013
Beta 1.461
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 0.6
Dist ATR (σ) 0.19
OdysseyHQ grade —
Confluence 1
Valuation
P/E (ttm) 29.572968
P/E (fwd) 24.94745
P/S 3.5804608
EV/EBITDA 17.656
P/B 6.016353
FCF yield 0.0037
PEG 1.3
Growth
Revenue yoy 0.166
EPS yoy 0.748
FCF yoy —
Revenue trend 8Q
Quality
Gross margin 0.50604
Operating margin 0.1314
Net margin 0.12224
ROE 0.24285
ROA 0.06845
Debt / Equity 0.53
Interest cov. 43.79
Technicals
RSI(14) 51.3
MACD signal bull
vs 50-DMA -1.94
vs 200-DMA 5.63
vs 52w high -11.25
HV-30 32.8
Sentiment
Analyst rec 1.30769
Target upside 27.1
Insider buy-sell 90d -24
Risk
Short interest 1.0199999
Days to cover 1.6
Next earnings 2026-07-30
Full AMZN dashboard →

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-04-30 1.15 1.06 +9.0% +7.1%
2026-02-05 1.35 1.23 +9.7% -10.4%
2025-10-30 1.34 1.17 +14.7% +24.8%
2025-07-31 1.19 1.01 +17.7% -7.8%
2025-05-08 0.97 0.94 +3.3% -4.8%
2025-02-06 0.86 0.92 -6.8% -9.6%
2024-11-04 1.14 0.88 +29.0% +1.0%
2024-08-06 0.36 0.90 -60.0% +4.1%
2024-05-02 0.09 0.11 -15.1% -4.9%
2024-02-08 0.14 0.12 +17.6% -3.8%
2023-11-09 0.33 0.14 +135.1% -8.1%
2023-08-09 0.32 0.02 +1326.0% +0.3%
2023-04-25 0.08 0.03 +198.2% -3.5%
2023-02-07 0.14 0.19 -24.8% -8.0%
2022-11-03 0.34 0.30 +13.2% +5.9%
2022-08-11 0.57 0.64 -11.6% -8.4%
2022-05-05 1.07 0.89 +20.8% -14.6%
2022-02-10 0.75 0.49 +54.5% -7.6%
2021-11-04 1.45 1.22 +19.1% -3.2%
2021-08-05 1.87 1.36 +37.1% -3.6%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
ILMN ★ $28B 33.9 31.5 6.4 25.7 10.6 68.3% 4.8% 6.1% 2.99%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0% —
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% — 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 49.23%

HolderShares% out
Blackrock Inc. 19,023,590 12.57%
Capital World Investors 15,549,960 10.28%
Vanguard Portfolio Management LLC 6,823,654 4.51%
Vanguard Capital Management LLC 6,594,836 4.36%
State Street Corporation 6,429,344 4.25%
WCM Investment Management, LLC 5,923,173 3.91%
AQR Capital Management, LLC 3,981,080 2.63%
Corvex Management LP 3,829,608 2.53%
Sessa Capital IM, L.P. 3,275,849 2.17%
Geode Capital Management, LLC 3,051,279 2.02%

Insider activity · 90d

3 buys / 12 sells · ratio 0.25 · Finnhub

  • Meister Keith A. BUY 6,780 @ $149.19
  • Ullem Scott B. BUY 11,030 @ $149.19
  • Davies Scott M SELL 20,953 @ $180.00
  • Skovronsky Daniel BUY 1,674 @ $164.28
  • Leckman Patricia SELL 21,259 @ $167.88
  • Leckman Patricia SELL 21,261 @ $164.82
  • Leckman Patricia SELL 21,300 @ $163.36
  • Leckman Patricia SELL 21,378 @ $162.78
  • Leckman Patricia SELL 21,752 @ $161.79
  • Leckman Patricia SELL 22,042 @ $163.02

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$95.0
Mean
$167.63158
High
$220.0
Analysts
19
Recommendation distribution · period 2026-07-01
7
10
8
2
1
Revision trend (2026-04-01 → 2026-07-01): net 12 → 14 +2 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-07-02 PRIMARY DOCUMENT view ·
4 2026-07-02 PRIMARY DOCUMENT view ·
4 2026-06-25 PRIMARY DOCUMENT view ·
4 2026-06-23 PRIMARY DOCUMENT view ·
8-K 2026-06-23 8-K view ·
4 2026-06-09 PRIMARY DOCUMENT view ·
4 2026-06-04 PRIMARY DOCUMENT view ·
4 2026-06-01 Insider transaction (Form 4) view ·
4 2026-06-01 PRIMARY DOCUMENT view ·
4 2026-06-01 PRIMARY DOCUMENT view ·
8-K 2026-05-26 8-K view ·
4 2026-05-22 PRIMARY DOCUMENT view ·
4 2026-05-22 PRIMARY DOCUMENT view ·
4 2026-05-22 PRIMARY DOCUMENT view ·
4 2026-05-22 PRIMARY DOCUMENT view ·
4 2026-05-22 PRIMARY DOCUMENT view ·
4 2026-05-22 PRIMARY DOCUMENT view ·
4 2026-05-22 PRIMARY DOCUMENT view ·
4 2026-05-22 PRIMARY DOCUMENT view ·
4 2026-05-14 Insider transaction (Form 4) view ·
4 2026-05-11 Insider transaction (Form 4) view ·
4 2026-05-07 PRIMARY DOCUMENT view ·
10-Q 2026-05-04 10-Q view ·
8-K 2026-04-30 8-K view ·
DEF 14A 2026-04-09 DEF 14A view ·
4 2026-04-02 PRIMARY DOCUMENT view ·
4 2026-04-02 PRIMARY DOCUMENT view ·
8-K 2026-04-02 8-K view ·
4 2026-03-09 PRIMARY DOCUMENT view ·
4 2026-03-09 PRIMARY DOCUMENT view ·
4 2026-03-09 PRIMARY DOCUMENT view ·
4 2026-03-09 PRIMARY DOCUMENT view ·
4 2026-03-09 PRIMARY DOCUMENT view ·
4 2026-03-09 PRIMARY DOCUMENT view ·
4 2026-03-09 PRIMARY DOCUMENT view ·
4 2026-03-09 PRIMARY DOCUMENT view ·
4 2026-02-24 PRIMARY DOCUMENT view ·
4 2026-02-18 PRIMARY DOCUMENT view ·
4 2026-02-18 PRIMARY DOCUMENT view ·
4 2026-02-18 PRIMARY DOCUMENT view ·
4 2026-02-18 PRIMARY DOCUMENT view ·
4 2026-02-18 PRIMARY DOCUMENT view ·
4 2026-02-18 PRIMARY DOCUMENT view ·
4 2026-02-18 PRIMARY DOCUMENT view ·
4 2026-02-17 PRIMARY DOCUMENT view ·
4 2026-02-17 PRIMARY DOCUMENT view ·
4 2026-02-17 PRIMARY DOCUMENT view ·
4 2026-02-17 PRIMARY DOCUMENT view ·
4 2026-02-17 PRIMARY DOCUMENT view ·
4 2026-02-17 PRIMARY DOCUMENT view ·
10-K 2026-02-12 10-K view ·
4 2026-02-11 PRIMARY DOCUMENT view ·
8-K 2026-02-05 8-K view ·
8-K 2026-01-30 8-K view ·
8-K 2026-01-13 8-K view ·
8-K 2026-01-08 8-K view ·
4 2026-01-05 PRIMARY DOCUMENT view ·
4 2025-12-16 PRIMARY DOCUMENT view ·
4 2025-12-09 PRIMARY DOCUMENT view ·
8-K 2025-11-25 8-K view ·

About ILMN

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration wit…

Options picks · ILMN

ITM + OTM ideas from the latest scan

Loading…

Congress trades · ILMN

STOCK Act disclosures

Loading…

SEC filings & insiders · ILMN

EDGAR · live

Loading…

Holders · ILMN

Institutions & insider activity

Loading…